New Protein Found in Hodgkin Lymphoma and Non-Hodgkin Lymphomas
Author Information
Author(s): Zhou Minglong, Fadlelmola Faisal M, Cohn Jason B, Skinnider Brian, Gascoyne Randy D, Banerjee Diponkar
Primary Institution: Centre for Translational and Applied Genomics, British Columbia Cancer Agency
Hypothesis
Can a novel 21 kDa protein serve as a specific biomarker for Hodgkin lymphoma and aggressive non-Hodgkin lymphomas?
Conclusion
The 21 kDa protein detected by the antibodies may be a potential marker for diagnosing and treating Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.
Supporting Evidence
- The antibodies R23.1 and R24.1 specifically label Hodgkin lymphoma and anaplastic large cell lymphoma cells.
- The 21 kDa protein is not expressed by activated T cells, indicating its specificity.
- Clone R24.1 mab recognizes a formalin-resistant epitope.
Takeaway
Researchers found a new protein that could help doctors identify and treat certain types of blood cancers better.
Methodology
Murine monoclonal antibodies were developed and tested against Hodgkin lymphoma and non-Hodgkin lymphoma cell lines.
Limitations
The study primarily focused on specific cell lines and may not represent all cases of Hodgkin lymphoma and non-Hodgkin lymphoma.
Participant Demographics
The study involved various Hodgkin lymphoma and non-Hodgkin lymphoma cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website